• Subcutaneous Biologic Drugs and Affiliated Technologies Market is projected to be worth over USD 180 billion by 2030

Subcutaneous Biologic Drugs and Affiliated Technologies Market is projected to be worth over USD 180 billion by 2030

Several approved therapeutic products, which are currently available as intravenous dosage forms, are being reformulated and evaluated for subcutaneous administration. Further, many existing drug delivery devices, including prefilled syringes, pen injectors, auto injectors, needle-free injectors and large volume wearable injectors, have been / are being designed for subcutaneous administration of biologics.

The USD 180+ billion (by 2030) financial opportunity associated with subcutaneous biologics, affiliated drug delivery systems and subcutaneous formulation technology licensing deals, has been analyzed across the following segments:

Subcutaneous Biologic Drugs and Affiliated Technologies Market, Trends by 2030 

Market Segment:  

Phase of development

Approved

Pre-registration & Phase III

Phase II & Phase II/III

Type of molecule

Cell and gene therapies

Monoclonal antibodies

Proteins

Peptides (recombinant)

Vaccines

Others

Target therapeutic area

Autoimmune disorders

Blood disorders 

Bone disorders 

Genetic disorders

Metabolic disorders

Neurological disorders

Oncological disorders

Respiratory disorders 

Others

Type of drug delivery system

Large volume wearable injectors 

Autoinjectors 

Prefilled syringes 

Needle-free injectors

Drug reconstitution systems

Revenues from licensing deals

Upfront payments

Milestone payments

Key geographical regions 

North America

Europe

Asia Pacific

Rest of the World

Request for PDF Sample: https://www.rootsanalysis.com/reports/314/request-sample.html 

The Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030 report features the following companies, which we identified to be key players in this domain:

Market Key Players:

Adocia

Ajinomoto Bio-Pharma Services

Arecor

Alteogen

Ascendis Pharma

Avadel Pharmaceuticals

Camurus

Creative BioMart

Creative Biolabs

DURECT

Eagle Pharmaceuticals

Halozyme Therapeutics

MedinCell

Xeris Pharmaceuticals

Serina Therapeutics

Request for PDF Sample: https://www.rootsanalysis.com/reports/314/request-sample.html 

Table of Contents

1.       Preface

2.       Executive Summary

3.       Introduction

4.       Subcutaneous Biologics: Current Market Landscape

5.       Case Study: Leading Subcutaneous Biologics

6.       Subcutaneous Formulation Technologies: Current Market Landscape

7.       Subcutaneous Formulation Technology Developers: Company Competitiveness Analysis

8.       Subcutaneous Formulation Technology Developers: Company Profiles

9.       Partnerships and Collaborations

10.     Subcutaneous Drug Delivery Systems: Current Market Landscape

11.     Swot Analysis

12.     Market Forecast and Opportunity Analysis

13.     Concluding Remarks

14.     Executive Insights

15.     Appendix 1:  Tabulated Data 

16.     Appendix 2: List Of Companies And Organization

Request For Customization: https://www.rootsanalysis.com/reports/314/request-customization.html 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com